Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms.

Guglielmo FF, Anupindi SA, Fletcher JG, Al-Hawary MM, Dillman JR, Grand DJ, Bruining DH, Chatterji M, Darge K, Fidler JL, Gandhi NS, Gee MS, Grajo JR, Huang C, Jaffe TA, Park SH, Rimola J, Soto JA, Taouli B, Taylor SA, Baker ME.

Radiographics. 2020 Jan 17:190091. doi: 10.1148/rg.2020190091. [Epub ahead of print]

PMID:
31951512
2.

Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.

Semaan S, Vietti Violi N, Lewis S, Chatterji M, Song C, Besa C, Babb JS, Fiel MI, Schwartz M, Thung S, Sirlin CB, Taouli B.

Eur Radiol. 2020 Feb;30(2):1020-1030. doi: 10.1007/s00330-019-06458-4. Epub 2019 Oct 31.

PMID:
31673837
3.

Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.

R MM, Shandil R, Panda M, Sadler C, Ambady A, Panduga V, Kumar N, Mahadevaswamy J, Sreenivasaiah M, Narayan A, Guptha S, Sharma S, Sambandamurthy VK, Ramachandran V, Mallya M, Cooper C, Mdluli K, Butler S, Tommasi R, Iyer PS, Narayanan S, Chatterji M, Shirude PS.

ACS Med Chem Lett. 2019 Sep 23;10(10):1480-1485. doi: 10.1021/acsmedchemlett.9b00343. eCollection 2019 Oct 10.

PMID:
31620237
4.

Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.

Panchal H, Wagner M, Chatterji M, Taouli B, McBride R, Patterson JR, Ungaro R, Dubinsky M, Cho J, Sachar DB.

Dig Dis Sci. 2019 Nov;64(11):3274-3283. doi: 10.1007/s10620-018-5434-4. Epub 2019 Jan 3.

PMID:
30607690
5.

Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's Disease.

Wagner M, Ko HM, Chatterji M, Besa C, Torres J, Zhang X, Panchal H, Hectors S, Cho J, Colombel JF, Harpaz N, Taouli B.

J Crohns Colitis. 2018 May 25;12(6):718-729. doi: 10.1093/ecco-jcc/jjx186.

PMID:
29300851
6.

Impact of Family Planning and Business Trainings on Private-Sector Health Care Providers in Nigeria.

Ugaz J, Leegwater A, Chatterji M, Johnson D, Baruwa S, Toriola M, Kinnan C.

Int Perspect Sex Reprod Health. 2017 Jun 1;43(2):51-65. doi: 10.1363/43e3717.

PMID:
29261503
7.

Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markers.

Besa C, Wagner M, Lo G, Gordic S, Chatterji M, Kennedy P, Stueck A, Thung S, Babb J, Smith A, Taouli B.

J Magn Reson Imaging. 2018 Jun;47(6):1552-1561. doi: 10.1002/jmri.25911. Epub 2017 Nov 28.

PMID:
29193508
8.

Imaging of Hepatocellular Carcinoma Response After 90Y Radioembolization.

Semaan S, Makkar J, Lewis S, Chatterji M, Kim E, Taouli B.

AJR Am J Roentgenol. 2017 Nov;209(5):W263-W276. doi: 10.2214/AJR.17.17993. Review.

PMID:
29072955
9.

Counseling Women and Couples on Family Planning: A Randomized Study in Jordan.

El-Khoury M, Thornton R, Chatterji M, Kamhawi S, Sloane P, Halassa M.

Stud Fam Plann. 2016 Sep;47(3):222-38. doi: 10.1111/sifp.69.

PMID:
27611319
10.

Causal inferences on the effectiveness of complex social programs: Navigating assumptions, sources of complexity and evaluation design challenges.

Chatterji M.

Eval Program Plann. 2016 Dec;59:128-140. doi: 10.1016/j.evalprogplan.2016.05.009. Epub 2016 Jun 18.

PMID:
27473589
11.

A randomized controlled trial of the impact of a family planning mHealth service on knowledge and use of contraception.

Johnson D, Juras R, Riley P, Chatterji M, Sloane P, Choi SK, Johns B.

Contraception. 2017 Jan;95(1):90-97. doi: 10.1016/j.contraception.2016.07.009. Epub 2016 Jul 13.

PMID:
27421767
12.

Is Lesional Stability in Vitiligo More Important Than Disease Stability for Performing Surgical Interventions? Results from a Multicentric Study.

Majid I, Mysore V, Salim T, Lahiri K, Chatterji M, Khunger N, Talwar S, Sachhidanand S, Barua S.

J Cutan Aesthet Surg. 2016 Jan-Mar;9(1):13-9. doi: 10.4103/0974-2077.178538.

13.

Is Household Wealth Associated With Use of Long-Acting Reversible and Permanent Methods of Contraception? A Multi-Country Analysis.

Ugaz JI, Chatterji M, Gribble JN, Banke K.

Glob Health Sci Pract. 2016 Mar 25;4(1):43-54. doi: 10.9745/GHSP-D-15-00234. Print 2016 Mar.

14.

Comparison of gadoxetic acid to gadobenate dimeglumine for assessment of biliary anatomy of potential liver donors.

Lewis S, Vasudevan P, Chatterji M, Besa C, Jajamovich G, Facciuto M, Taouli B.

Abdom Radiol (NY). 2016 Jul;41(7):1300-9. doi: 10.1007/s00261-016-0693-z.

PMID:
26960727
15.

Effectiveness of evidence-based medicine on knowledge, attitudes, and practices of family planning providers: a randomized experiment in Jordan.

El-Khoury M, Thornton R, Chatterji M, Choi SK.

BMC Health Serv Res. 2015 Oct 2;15:449. doi: 10.1186/s12913-015-1101-z.

16.

Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors.

Ugaz JI, Chatterji M, Gribble JN, Mitchell S.

Int J Gynaecol Obstet. 2015 Aug;130 Suppl 3:E3-7. doi: 10.1016/j.ijgo.2015.03.021. Epub 2015 Apr 14.

17.

Saving for delivery through technology: an inquiry into an electronic commitment savings product for maternal healthcare in Kenya.

van Bastelaer T, Woodman B, Chatterji M, Long D.

Int J Health Plann Manage. 2016 Oct;31(4):e254-e272. doi: 10.1002/hpm.2292. Epub 2015 Apr 28.

PMID:
25920603
18.

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

Hameed P S, Solapure S, Patil V, Henrich PP, Magistrado PA, Bharath S, Murugan K, Viswanath P, Puttur J, Srivastava A, Bellale E, Panduga V, Shanbag G, Awasthy D, Landge S, Morayya S, Koushik K, Saralaya R, Raichurkar A, Rautela N, Roy Choudhury N, Ambady A, Nandishaiah R, Reddy J, Prabhakar KR, Menasinakai S, Rudrapatna S, Chatterji M, Jiménez-Díaz MB, Martínez MS, Sanz LM, Coburn-Flynn O, Fidock DA, Lukens AK, Wirth DF, Bandodkar B, Mukherjee K, McLaughlin RE, Waterson D, Rosenbrier-Ribeiro L, Hickling K, Balasubramanian V, Warner P, Hosagrahara V, Dudley A, Iyer PS, Narayanan S, Kavanagh S, Sambandamurthy VK.

Nat Commun. 2015 Mar 31;6:6715. doi: 10.1038/ncomms7715.

19.

Can mobile phone messages to drug sellers improve treatment of childhood diarrhoea?--A randomized controlled trial in Ghana.

Friedman W, Woodman B, Chatterji M.

Health Policy Plan. 2015 Mar;30 Suppl 1:i82-92. doi: 10.1093/heapol/czu122.

PMID:
25759456
20.

A false dichotomy: RCTs and their contributions to evidence-based public health.

Hatt LE, Chatterji M, Miles L, Comfort AB, Bellows BW, Okello FO.

Glob Health Sci Pract. 2015 Mar 5;3(1):138-40. doi: 10.9745/GHSP-D-14-00245. Print 2015 Mar. No abstract available.

21.

Public health response to a measles outbreak in a large correctional facility, Queensland, 2013.

Chatterji M, Baldwin AM, Prakash R, Vlack SA, Lambert SB.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E294-7.

22.

Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.

Lewis S, Kamath A, Chatterji M, Patel A, Shyknevsky I, Dyvorne HA, Kuehn B, Taouli B.

AJR Am J Roentgenol. 2015 Jan;204(1):59-68. doi: 10.2214/AJR.13.11695.

PMID:
25539238
23.

2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis.

Naik M, Ghorpade S, Jena LK, Gorai G, Narayan A, Guptha S, Sharma S, Dinesh N, Kaur P, Nandishaiah R, Bhat J, Balakrishnan G, Humnabadkar V, Ramachandran V, Naviri LK, Khadtare P, Panda M, Iyer PS, Chatterji M.

ACS Med Chem Lett. 2014 Jul 11;5(9):1005-9. doi: 10.1021/ml5001933. eCollection 2014 Sep 11.

24.

UDP-N-acetylmuramic acid l-alanine ligase (MurC) inhibition in a tolC mutant Escherichia coli strain leads to cell death.

Humnabadkar V, Prabhakar KR, Narayan A, Sharma S, Guptha S, Manjrekar P, Chinnapattu M, Ramachandran V, Hameed SP, Ravishankar S, Chatterji M.

Antimicrob Agents Chemother. 2014 Oct;58(10):6165-71. doi: 10.1128/AAC.02890-14. Epub 2014 Aug 11.

25.

Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.

Bellale E, Naik M, V B V, Ambady A, Narayan A, Ravishankar S, Ramachandran V, Kaur P, McLaughlin R, Whiteaker J, Morayya S, Guptha S, Sharma S, Raichurkar A, Awasthy D, Achar V, Vachaspati P, Bandodkar B, Panda M, Chatterji M.

J Med Chem. 2014 Aug 14;57(15):6572-82. doi: 10.1021/jm500833f. Epub 2014 Jul 16.

PMID:
24967731
26.

1,4-azaindole, a potential drug candidate for treatment of tuberculosis.

Chatterji M, Shandil R, Manjunatha MR, Solapure S, Ramachandran V, Kumar N, Saralaya R, Panduga V, Reddy J, Prabhakar KR, Sharma S, Sadler C, Cooper CB, Mdluli K, Iyer PS, Narayanan S, Shirude PS.

Antimicrob Agents Chemother. 2014 Sep;58(9):5325-31. doi: 10.1128/AAC.03233-14. Epub 2014 Jun 23.

27.

DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.

Aronhime S, Calcagno C, Jajamovich GH, Dyvorne HA, Robson P, Dieterich D, Fiel MI, Martel-Laferriere V, Chatterji M, Rusinek H, Taouli B.

J Magn Reson Imaging. 2014 Jul;40(1):90-8. doi: 10.1002/jmri.24341. Epub 2013 Nov 4.

28.

Lead optimization of 1,4-azaindoles as antimycobacterial agents.

Shirude PS, Shandil RK, Manjunatha MR, Sadler C, Panda M, Panduga V, Reddy J, Saralaya R, Nanduri R, Ambady A, Ravishankar S, Sambandamurthy VK, Humnabadkar V, Jena LK, Suresh RS, Srivastava A, Prabhakar KR, Whiteaker J, McLaughlin RE, Sharma S, Cooper CB, Mdluli K, Butler S, Iyer PS, Narayanan S, Chatterji M.

J Med Chem. 2014 Jul 10;57(13):5728-37. doi: 10.1021/jm500571f. Epub 2014 Jun 20.

PMID:
24874895
29.

4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.

Naik M, Humnabadkar V, Tantry SJ, Panda M, Narayan A, Guptha S, Panduga V, Manjrekar P, Jena LK, Koushik K, Shanbhag G, Jatheendranath S, Manjunatha MR, Gorai G, Bathula C, Rudrapatna S, Achar V, Sharma S, Ambady A, Hegde N, Mahadevaswamy J, Kaur P, Sambandamurthy VK, Awasthy D, Narayan C, Ravishankar S, Madhavapeddi P, Reddy J, Prabhakar K, Saralaya R, Chatterji M, Whiteaker J, McLaughlin B, Chiarelli LR, Riccardi G, Pasca MR, Binda C, Neres J, Dhar N, Signorino-Gelo F, McKinney JD, Ramachandran V, Shandil R, Tommasi R, Iyer PS, Narayanan S, Hosagrahara V, Kavanagh S, Dinesh N, Ghorpade SR.

J Med Chem. 2014 Jun 26;57(12):5419-34. doi: 10.1021/jm5005978. Epub 2014 Jun 11.

PMID:
24871036
30.

Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.

Shirude PS, Shandil R, Sadler C, Naik M, Hosagrahara V, Hameed S, Shinde V, Bathula C, Humnabadkar V, Kumar N, Reddy J, Panduga V, Sharma S, Ambady A, Hegde N, Whiteaker J, McLaughlin RE, Gardner H, Madhavapeddi P, Ramachandran V, Kaur P, Narayan A, Guptha S, Awasthy D, Narayan C, Mahadevaswamy J, Vishwas KG, Ahuja V, Srivastava A, Prabhakar KR, Bharath S, Kale R, Ramaiah M, Choudhury NR, Sambandamurthy VK, Solapure S, Iyer PS, Narayanan S, Chatterji M.

J Med Chem. 2013 Dec 12;56(23):9701-8. doi: 10.1021/jm401382v. Epub 2013 Nov 21.

PMID:
24215368
31.

L.E.A.D.: a framework for evidence gathering and use for the prevention of obesity and other complex public health problems.

Chatterji M, Green LW, Kumanyika S.

Health Educ Behav. 2014 Feb;41(1):85-99. doi: 10.1177/1090198113490726. Epub 2013 Jun 19. Review.

PMID:
23785069
32.

LC-MS based assay to measure intracellular compound levels in Mycobacterium smegmatis: linking compound levels to cellular potency.

Bhat J, Narayan A, Venkatraman J, Chatterji M.

J Microbiol Methods. 2013 Aug;94(2):152-158. doi: 10.1016/j.mimet.2013.05.010. Epub 2013 Jun 6.

33.

Comparison of nonenhanced MR angiographic subtraction techniques for infragenual arteries at 1.5 T: a preliminary study.

Lim RP, Fan Z, Chatterji M, Baadh A, Atanasova IP, Storey P, Kim DC, Kim S, Hodnett PA, Ahmad A, Stoffel DR, Babb JS, Adelman MA, Xu J, Li D, Lee VS.

Radiology. 2013 Apr;267(1):293-304. doi: 10.1148/radiol.12120859. Epub 2013 Jan 7.

34.

When does a radiologist's recommendation for follow-up result in high-cost imaging?

Lee SI, Krishnaraj A, Chatterji M, Dreyer KJ, Thrall JH, Hahn PF.

Radiology. 2012 Feb;262(2):544-9. doi: 10.1148/radiol.11111091. Epub 2011 Nov 14.

PMID:
22084210
35.

Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts.

Chatterji M, Mercado CL, Moy L.

Magn Reson Imaging Clin N Am. 2010 May;18(2):207-24, viii. doi: 10.1016/j.mric.2010.02.011. Review.

PMID:
20494307
36.
37.

Systems-based practice defined: taxonomy development and role identification for competency assessment of residents.

Graham MJ, Naqvi Z, Encandela J, Harding KJ, Chatterji M.

J Grad Med Educ. 2009 Sep;1(1):49-60. doi: 10.4300/01.01.0009.

38.

Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.

Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng HL, DeVido J, Alt FW, Ferguson DO, Schatz DG, Sekiguchi J.

Blood. 2009 Mar 26;113(13):2965-75. doi: 10.1182/blood-2008-07-165167. Epub 2009 Jan 6.

39.

Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia.

Abramson JS, Chatterji M, Rahemtullah A.

N Engl J Med. 2008 Dec 18;359(25):2707-18. doi: 10.1056/NEJMcpc0806981. No abstract available.

PMID:
19092156
40.

Case records of the Massachusetts General Hospital. Case 38-2008. A 58-year-old man with hemophilia, hepatocellular carcinoma, and intractable bleeding.

Dzik WH, Laposata M, Hertl M, Sandberg WS, Chatterji M, Misdraji J.

N Engl J Med. 2008 Dec 11;359(24):2587-97. doi: 10.1056/NEJMcpc0807506. No abstract available.

PMID:
19073979
41.

Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation.

Chatterji M, Unniraman S, McBride KM, Schatz DG.

J Immunol. 2007 Oct 15;179(8):5274-80.

42.

The factors influencing transactional sex among young men and women in 12 sub-Saharan African countries.

Chatterji M, Murray N, London D, Anglewicz P.

Soc Biol. 2005 Spring-Summer;52(1-2):56-72.

PMID:
17619631
43.

Factors related to induced abortion among young women in Edo State, Nigeria.

Murray N, Winfrey W, Chatterji M, Moreland S, Dougherty L, Okonofua F.

Stud Fam Plann. 2006 Dec;37(4):251-68.

PMID:
17209283
44.

Mobilization of RAG-generated signal ends by transposition and insertion in vivo.

Chatterji M, Tsai CL, Schatz DG.

Mol Cell Biol. 2006 Feb;26(4):1558-68.

45.

Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis.

Mehta A, Brewington R, Chatterji M, Zoubine M, Kinasewitz GT, Peer GT, Chang AC, Taylor FB Jr, Shnyra A.

Shock. 2004 Nov;22(5):423-30.

PMID:
15489634
46.
47.

New concepts in the regulation of an ancient reaction: transposition by RAG1/RAG2.

Chatterji M, Tsai CL, Schatz DG.

Immunol Rev. 2004 Aug;200:261-71. Review.

PMID:
15242411
48.

DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase.

Tsai CL, Chatterji M, Schatz DG.

Nucleic Acids Res. 2003 Nov 1;31(21):6180-90.

49.

Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.

Chatterji M, Sengupta S, Nagaraja V.

Arch Microbiol. 2003 Nov;180(5):339-46. Epub 2003 Sep 11.

PMID:
13680098
50.

A hairpin near the 5' end stabilises the DNA gyrase mRNA in Mycobacterium smegmatis.

Unniraman S, Chatterji M, Nagaraja V.

Nucleic Acids Res. 2002 Dec 15;30(24):5376-81.

Supplemental Content

Loading ...
Support Center